More than 300 global leaders, health and development experts, vaccinators, celebrities, philanthropists, and business leaders will gather tomorrow in Abu Dhabi in the first Global Vaccine Summit to endorse the critical role that vaccines and immunization play in giving children a healthy start to life. Despite tremendous progress, one child still dies every 20 seconds from preventable diseases like pneumonia, rotavirus, measles, and meningitis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61396-bill-and-melinda-gates-foundation-first-global-vaccine-summit
Building upon its efforts to provide greater access to vaccines and other health care services for populations in need, Walgreens (NYSE: WAG) (Nasdaq: WAG) is partnering with the United Nations Foundation this flu season, to help provide up to 3 million life-saving vaccines to children in developing countries through a donation to the Foundation’s Shot@Life campaign.
To view Multimedia News Release, go to http://www.multivu.com/players/English/62923-walgreens-flu-season2013
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs.
Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older.
To view the multimedia release go to:
http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
During flu season, when fever, aches, and chills hit, it is easy to forget one’s manners. A recent survey of more than 1,000 Americans found that nearly two-thirds (64%) of those who had influenza in the past three years admit to being “That Guy,” who despite experiencing flu symptoms, continues to go about his/her daily activities.
As part of its “Are You That Guy?” influenza education campaign, the National Foundation for Infectious Diseases (NFID) is partnering with the Emily Post Institute to remind Americans to do the responsible thing during flu season and practice behavior that will help limit the spread of influenza, a highly contagious virus. The campaign also reminds Americans to see a doctor quickly if flu strikes. The campaign offers flu etiquette tips for managing common situations where the flu virus might be shared from one person to another, such as shaking hands during a business meeting, over a family dinner, or when faced with a fellow airplane traveler who is showing signs of flu.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53536-nfid-emily-post-institute-educate-about-spreading-manners-not-influenza
CVS/pharmacy and MinuteClinic announced their “You vs. Flu” campaign today. Flu vaccinations are now available at all CVS/pharmacy and MinuteClinic locations nationwide to help consumers win against the flu. CVS/pharmacy has more than 7,200 locations and MinuteClinic has nearly 600 locations inside select CVS/pharmacy stores.
Flu shots are being provided by CVS pharmacists and MinuteClinic nurse practitioners and physician assistants every day, including evenings and weekends, with no appointment necessary. The Centers for Disease Control and Prevention (CDC) recommends that everyone ages six months and older get a flu shot as soon as vaccine is available, including those who were vaccinated last flu season.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51328-cvs-minuteclinic-flu-shot
Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
The United Nations Foundation’s Shot@Life campaign marks World Pneumonia Day, November 12, by asking Americans to raise awareness, funds and advocate to members of Congress to support global immunization programs. Pneumonia kills nearly a million children under the age of five each year and almost half of those deaths are vaccine-preventable.
“Around the world one in five children lack access to the vaccines they need,” said Devi Thomas, Director, UN Foundation’s Shot@Life campaign. “By raising awareness, funding and asking members of Congress to support global immunization programs we can ensure that every child, no matter where they live, is given a shot at a healthy life.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7616651-shotatlife-united-nations-vaccines/
During flu season, when fever, aches, and chills hit, it is easy to forget one’s manners. A recent survey of more than 1,000 Americans found that nearly two-thirds (64%) of those who had influenza in the past three years admit to being “That Guy,” who despite experiencing flu symptoms, continues to go about his/her daily activities.
As part of its “Are You That Guy?” influenza education campaign, the National Foundation for Infectious Diseases (NFID) is partnering with the Emily Post Institute to remind Americans to do the responsible thing during flu season and practice behavior that will help limit the spread of influenza, a highly contagious virus. The campaign also reminds Americans to see a doctor quickly if flu strikes. The campaign offers flu etiquette tips for managing common situations where the flu virus might be shared from one person to another, such as shaking hands during a business meeting, over a family dinner, or when faced with a fellow airplane traveler who is showing signs of flu.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53536-nfid-emily-post-institute-educate-about-spreading-manners-not-influenza
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
